+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Low proliferative activity A possible prognostic factor for survival in advanced ovarian cancer



Low proliferative activity A possible prognostic factor for survival in advanced ovarian cancer



Pathology International 46(Suppl. 1): 392




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 032204402

Download citation: RISBibTeXText


Related references

Prognostic significance of p53 and bcl-2 expression correlated with proliferative activity in different subtypes of advanced epithelial ovarian cancer. Journal of Cancer Research & Clinical Oncology 127(Suppl. 1): S61, 2001

Nuclear morphometry: a strong prognostic factor for survival after secondary surgery in advanced ovarian cancer. International Journal of Gynecological Cancer 2(4): 198-206, 1992

HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD Consortium. Oncotargets and Therapy 7: 1563-1569, 2014

Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients. International Journal of Cancer 79(5): 449-454, Oct 23, 1998

Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer. Onkologie 31(6): 315-320, 2008

A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival. European Journal of Cancer and Clinical Oncology 25(12): 1901, 1989

SERPINB3 in the chicken model of ovarian cancer: a prognostic factor for platinum resistance and survival in patients with epithelial ovarian cancer. Plos One 7(11): E49869, 2013

The prognostic effects of performance status (PS) and quality of life (QoL) scores on progression-free survival (PFS) and overall survival (OS) in advanced ovarian cancer. Journal of Clinical Oncology 24(18_Suppl): 5066-5066, 2016

The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer. Gynecologic Oncology 108(1): 100-105, 2007

Stromal compartment as a survival prognostic factor in advanced ovarian carcinoma. International Journal of Gynecological Cancer 20(1): 28-33, 2010

A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (measured with the log (relative risk)) as main objectives. European Journal of Cancer and Clinical Oncology 25(4): 711-720, 1989

Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer. European Journal of Surgical Oncology 29(1): 69-73, 2003

Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Gynecologic Oncology 106(1): 69-74, 2007

Matrix metalloproteinase-9 expression increases from benign ovarian tumor to advanced ovarian cancer and predicts survival in advanced ovarian cancer. Gynecologic Oncology 80(2): 324, 2001

Mib-1 evaluated proliferative activity in ovarian cancer with respect to prognostic significance. Anticancer Research 17(1b): 775-780, 1997